Medicine & TechnologyAmerican and Swedish experts have discovered a specific protein in the blood that can indicate an early diagnosis of Alzheimer's dementia. The blood test can potentially indicate the risk of developing the disease years before symptoms occur.
A recent study finds that elderly people living alone are 30% more likely to develop dementia. Experts believe that living alone is associated with increased stress, feelings of loneliness, and lack of cognitive stimulation, which might have contributed to the increasing number of cases.
While observing brain cells affected by Alzheimer's disease, researchers discover a suppressor gene and develop a new rapid drug-screening system for treatment.
Scientists have directly linked non-alcoholic fatty liver disease with 'neuroinflammatory complications,' which eventually develop into Alzheimer's Disease.
Women who spent long years hitting the books and attending school are less likely to develop memory loss and dementia, researchers of a new study claim. Furthermore, the authors say that Alzheimer's disease might not be in the books for these women with the help of their previous education. Click the link above to learn more.
Medical researchers from Hong Kong have come up with a new approach to detect the early onset of Alzheimer's disease a decade before symptoms become apparent. The new and non-invasive method involves using MRI scans and tracking glucose distributions in the brain.
In a recent study, scientists are finding a connection between Herpes Simplex Type 1 and Alzheimer's disease. Using brain models, they noticed a growth of cells that resembles amyloid plaques, evident in patients with Alzheimer's, when triggered with HSV-1. Click the link above to learn more.
The measure of how fast a person’s pupils dilate during a cognitive test may be a low cost method to check for a genetic risk of developing the Alzheimer’s Disease.
The 6KApoEp, also known as peptide antagonist, was shown to reduce Alzheimer’s-associated beta-amyloid (β-amyloid) accumulation and tau pathologies in the brain, as well as improving learning and memory in mice genetically engineered to mimic symptoms of Alzheimer’s disease